Methyl nutrients, DNA methylation, and cardiovascular disease

Molecular Nutrition and Food Research

Volumn 58, Issue 1, 2014, Pages 172-182

  Glier, Melissa B ^a   Green, Timothy J ^a   Devlin, Angela M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

B vitamins; Cardiovascular disease; DNA methylation; S adenosylmethionine

Indexed keywords

AMINO ACID; CYSTEINE; FOLIC ACID; METHIONINE; S ADENOSYLMETHIONINE; VITAMIN B COMPLEX;

ATHEROSCLEROSIS; B-VITAMINS; CARDIOVASCULAR DISEASE; DIET; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HUMAN; HYPERHOMOCYSTEINEMIA; LIPID METABOLISM; METABOLISM; NUTRITIONAL STATUS; REVIEW; RISK FACTOR;

B-VITAMINS; CARDIOVASCULAR DISEASE; DNA METHYLATION; S-ADENOSYLMETHIONINE;

AMINO ACIDS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CYSTEINE; DIET; DNA METHYLATION; EPIGENESIS, GENETIC; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; LIPID METABOLISM; METHIONINE; NUTRITIONAL STATUS; RISK FACTORS; S-ADENOSYLMETHIONINE; VITAMIN B COMPLEX;

EID: 84890467597     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200636     Document Type: Review

References (90)

1. Herman, J. G., Baylin, S. B., Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349, 2042-2054.
2. Waterland, R. A., Jirtle, R. L., Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell Biol. 2003, 23, 5293-5300.
3. Laukkanen, M. O., Mannermaa, S., Hiltunen, M. O., Aittomaki, S. et al., Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 2171-2178.
4. Hiltunen, M. O., Turunen, M. P., Hakkinen, T. P., Rutanen, J. et al., DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc. Med. 2002, 7, 5-11.
5. Lund, G., Andersson, L., Lauria, M., Lindholm, M. et al., DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol. Chem. 2004, 279, 29147-29154.
6. Post, W. S., Goldschmidt-Clermont, P. J., Wilhide, C. C., Heldman, A. W. et al., Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 1999, 43, 985-991.
7. Zhu, S., Goldschmidt-Clermont, P. J., Dong, C., Inactivation of the monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation 2005, 112, 1353-1361.
8. Finkelstein, J. D., Methionine metabolism in liver diseases. Am. J. Clin. Nutr. 2003, 77, 1094-1095.
9. Stover, P. J., Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 2004, 62, S3-S12.
10. Mato, J. M., Martinez-Chantar, M. L., Lu, S. C., Methionine metabolism and liver disease. Ann. Rev. Nutr. 2008, 28, 273-293.
11. Garrow, T. A., Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J. Biol. Chem. 1996, 271, 22831-22838.
12. Vance, J. E., Vance, D. E., Phospholipid biosynthesis in mammalian cells. Biochem. Cell Biol. 2004, 82, 113-128.
13. Selhub, J., Homocysteine metabolism. Ann. Rev. Nutr. 1999, 19, 217-246.
14. Brosnan, J. T., Brosnan, M. E., The sulfur-containing amino acids: an overview. J. Nutr. 2006, 136, 1636S-1640S.
15. Law, J. A., Jacobsen, S. T, Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 2010, 11, 204-220.
16. Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D. et al., Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462, 315-322.
17. Bestor, T. H., The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000, 9, 2395-2402.
18. Reik, W., Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447, 425-432.
19. Probst, A. V., Almouzni, G., Heterochromatin establishment in the context of genome-wide epigenetic reprogramming. Trends Genet. 2011, 27, 177-185.
20. Waterland, R. A., Lin, J. R., Smith, C. A., Jirtle, R. L., Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum. Mol. Genet. 2006, 15, 705-716.
21. Devlin, A. M., Singh, R., Wade, R. E., Innis, S. M. et al., Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J. Biol. Chem. 2007, 282, 37082-37090.
22. Glier, M. B., Ngai, Y. F., Sulistyoningrum, D. C., Aeliunas, R. E. et al., Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia. Epigenetics 2013, 8, 44-53.
23. Deaton, A. M., Bird, A., CpG islands and the regulation of transcription. Genes Dev. 2011, 25, 1010-1022.
24. Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z. et al., The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 2009, 41, 178-186.
25. Wutz, A., Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat. Rev. Genet. 2011, 12, 542-553.
26. Ideraabdullah, F. Y., Vigneau, S., Bartolomei, M. S., Genomic imprinting mechanisms in mammals. Mutat. Res. 2008, 647, 77-85.
27. Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C. et al., Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7, 847-854.
28. Ballestar, E., Wolffe, A. P., Methyl-CpG-binding proteins. Eur. J. Biochem. 2001, 268, 1-6.
29. Jacob, R. A., Gretz, D. M., Taylor, P. C., James, S. J. et al., Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr. 1998, 128, 1204-1212.
30. Rampersaud, G. C., Kauwell, G. P., Hutson, A. D., Cerda, J. J. et al., Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 2000, 72, 998-1003.
31. Frosst, P., Blom, H. J., Milos, R., Goyette, P. et al., A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10, 111-113.
32. Devlin, A. M., Clarke, R., Birks, J., Evans, J. G. et al., Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am. J. Clin. Nutr. 2006, 83, 708-713.
33. Castro, R., Rivera, I., Ravasco, P., Camilo, M. E. et al., 5, 10-methylenetetrahydrofolate reductase (MTHFR) 677C>T and 1298A>C mutations are associated with DNA hypomethylation. J. Med. Genet. 2004, 41, 454-458.
34. Sohn, K. J., Jang, H., Campan, M., Weisenberger, D. J. et al., The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification. Int. J. Cancer 2009, 124, 1999-2005.
35. Friso, S., Choi, S. W., Girelli, D., Mason, J. B. et al., A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA 2002, 99, 5606-5611.
36. Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P. et al., Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 2000, 275, 29318-29323.
37. Castro, R., Rivera, I., Struys, E. A., Jansen, E. E. et al., Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 2003, 49, 1292-1296.
38. Dayal, S., Bottiglieri, T., Arning, E., Maeda, N. et al., Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ. Res. 2001, 88, 1203-1209.
39. Devlin, A. M., Arning, E., Bottiglieri, T., Faraci, F. M. et al., Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 2004, 103, 2624-2629.
40. Devlin, A. M., Bottiglieri, T., Domann, F. E., Lentz, S. R., Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J. Biol. Chem. 2005, 280, 25506-25511.
41. Hoffman, D. R., Marion, D. W., Cornatzer, W. E., Duerre, J. A., S-adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of l-methionine, l-homocystein, and adenosine. J. Biol. Chem. 1980, 255, 10822-10827.
42. De Cabo, S. F., Hazen, M. J., Molero, M. L., Fernandez-Piqueras, J., S-adenosyl-l-homocysteine: a non-cytotoxic hypomethylating agent. Experientia 1994, 50, 658-659.
43. Heil, S. G., Riksen, N. P., Boers, G. H., Smulders, Y. et al., DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients. Molec. Genet. Metab. 2007, 91, 55-60.
44. Fux, R., Kloor, D., Hermes, M., Rock, T. et al., Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers. Am. J. Physiol. Renal Physiol. 2005, 289, F786-F792.
45. Ingrosso, D., Cimmino, A., Perna, A. F., Masella, L. et al., Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003, 361, 1693-1699.
46. Choumenkovitch, S. F., Selhub, J., Bagley, P. J., Maeda, N. et al., In the cystathionine {beta}-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific. J. Nutr. 2002, 132, 2157-2160.
47. Homocysteine studies collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288, 2015-2022.
48. Bonaa, K. H., Njolstad, I., Ueland, P. M., Schirmer, H. et al., For the NORVIT trial investigators, homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 2006, 354, 1578-1588.
49. Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D. et al., Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 2004, 291, 565-575.
50. Meyers, M. R., Gokce, N., Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr. Opinion Endo. Diabetes Obesity 2007, 14, 365-369.
51. Bellamy, M. F., McDowell, I. F., Ramsey, M. W., Brownlee, M. et al., Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 1998, 98, 1848-1852.
52. Lentz, S. R., Erger, R. A., Dayal, S., Maeda, N. et al., Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H970-H975.
53. Dayal, S., Arning, E., Bottiglieri, T., Boger, R. H. et al., Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 2004, 35, 1957-1962.
54. Weiss, N., Heydrick, S. J., Postea, O., Keller, C. et al., Influence of hyperhomocysteinemia on the cellular redox state-impact on homocysteine-induced endothelial dysfunction. Clin. Chem. Lab Med. 2003, 41, 1455-1461.
55. Dayal, S., Devlin, A. M., McCaw, R. B., Liu, M. L. et al., Cerebral vascular dysfunction in methionine synthase-deficient mice. Circulation 2005, 112, 737-744.
56. Antoniades, C., Shirodaria, C., Leeson, P., Baarholm, O. A. et al., MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009, 119, 2507-2515.
57. Sundler, R., Akesson, B., Regulation of phospholipid biosynthesis in isolated rat hepatocytes. Effect of different substrates. J. Biol. Chem. 1975, 250, 3359-3367.
58. DeLong, C. J., Shen, Y. J., Thomas, M. J., Cui, Z., Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J. Biol. Chem. 1999, 274, 29683-29688.
59. Yao, Z. M., Vance, D. E., The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem. 1988, 263, 2998-3004.
60. Yao, Z. M., Vance, D. E., Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes. J. Biol. Chem. 1989, 264, 11373-11380.
61. Namekata, K., Enokido, Y., Ishii, I., Nagai, Y. et al., Abnormal lipid metabolism in cystathionine {beta}-synthase-deficient mice, an animal model for hyperhomocysteinemia. J. Biol. Chem. 2004, 279, 52961-52969.
62. Mikael, L. G., Genest, J., Jr., Rozen, R., Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ. Res. 2006, 98, 564-571.
63. Qujeq D, Omran T. S., Hosini L., Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin. Biochem. 2001, 34, 97-101.
64. van Straten, E. M. E., Bloks, V. W., Huijkman, N. C. A., Baller, J. F. W. et al., The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. Am. J. Physiol.- Regul. Int. Comp. Physiol. 2010, 298, R275-R282.
65. El-Khairy, L., Ueland, P. M., Refsum, H., Graham, I. M. et al., Plasma total cysteine as a risk factor for vascular disease the European Concerted Action Project. Circulation 2001, 103, 2544-2549.
66. van den Brandhof, W. E., Haks, K., Schouten, E. G., Verhoef, P., The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis 2001, 157, 403-409.
67. Elshorbagy, A. K., Nurk, E., Gjesdal, C. G., Tell, G. S. et al., Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am. J. Clin. Nutr. 2008, 88, 738-746.
68. Okawa, H., Morita, T., Sugiyama, K., Cysteine supplementation decreases plasma homocysteine concentration in rats fed on a low-casein diet in rats. Biosc. Biotech. Biochem. 2007, 71, 91-97.
69. Elshorbagy, A. K., Valdivia-Garcia, M., Mattocks, D. A. L., Plummer, J. D. et al., Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase. J. Lipid Res. 2011, 52, 104-112.
70. Elshorbagy, A. K., Church, C., Valdivia-Garcia, M., Smith, A. D. et al., Dietary cystine level affects metabolic rate and glycaemic control in adult mice. J. Nutr. Biochem. 2012, 23, 332-340.
71. Araki, A., Sako, Y., Fukushima, Y., Matsumoto, M. et al., Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989, 79, 139-146.
72. Mansoor, M. A., Bergmark, C., Svardal, A. M., Lonning, P. E. et al., Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol. 1995, 15, 232-240.
73. Verhoef, P., Stampfer, M. J., Buring, J. F., Gaziano, J. M. et al., Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am. J. Epidemiol. 1996, 143, 845-859.
74. Jacob, N., Bruckert, E., Giral, P., Foglietti, M. J. et al., Cysteine is a cardiovascular risk factor in hyperlipidemic patients. Atherosclerosis 1999, 146, 53-59.
75. Wang, J. C., Bennett, M., Aging and atherosclerosis. Circ. Res. 2012, 111, 245-259.
76. Libby, P., Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2045-2051.
77. Kim, M., Long, T. I., Arakawa, K., Wang, R. et al., DNA methylation as a biomarker for cardiovascular disease risk. PLoS ONE 2010, 5, e9692.
78. Baccarelli, A., Tarantini, L., Wright, R. O., Bollati, V. et al., Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics 2010, 5, 1-7.
79. Cash, H. L., McGarvey, S. T., Houseman, E. A., Marsit, C. J., et al., Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan islanders. Epigenetics 2011, 6, 1257-1264.
80. Friso, S., Lotto, V., Choi, S. W., Girelli, D. et al., Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. J. Med. Genet. 2012, 49, 192-199.
81. De Wals, P., Tairou, F., Van Allen, M. I., Uh, S. H. et al., Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 2007, 357, 135-142.
82. Colapinto, C. K., O'Connor, D. L., Tremblay, M. S., Folate status of the population in the Canadian Health Measures Survey. CMAJ 2011, 183, E100-E106.
83. Pfeiffer, C. M., Johnson, C. L., Jain, R. B., Yetley, E. A. et al., Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am. J. Clin. Nutr. 2007, 86, 718-727.
84. Boulet, S. L., Yang, Q., Mai, C., Kirby, R. S. et al., Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res. A Clin. Mol. Teratol. 2008, 82, 527-532.
85. Jung, A. Y., Smulders, Y., Verhoef, P., Kok, F. J. et al., No effect of folic acid supplementation on global DNA methylation in men and women with moderately elevated homocysteine. PLoS One 2011, 6, e24976
86. Crider, K. S., Quinlivan, E. P., Berry, R. J., Hao, L. et al., Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age. PLoS One 2011, 6, e28144
87. Pizzolo, F., Blom, H. J., Choi, S. W., Girelli, D. et al., Folic acid effects on S-adenosylmethionine, S-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. J. Am. Coll. Nutr. 2011, 30, 11-18.
88. Scott, J. M., Folate and vitamin B12. Proc. Nutr. Soc. 1999, 58, 441-448.
89. Morris, M. S., Jacques, P. F., Rosenberg, I. H., Selhub, J., Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr. 2007, 85, 193-200.
90. MacFarlane, A. J., Greene-Finestone, L. S., Shi, Y., Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey. Am. J. Clin. Nutr. 2011, 94, 1079-1087.